Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 117
2003 136
2004 157
2005 169
2006 155
2007 109
2008 115
2009 169
2010 212
2011 222
2012 214
2013 198
2014 213
2015 213
2016 273
2017 276
2018 257
2019 231
2020 258
2021 259
2022 255
2023 206

Text availability

Article attribute

Article type

Publication date

Search Results

4,286 results

Results by year

Filters applied: . Clear all
Page 1
Microbial 'dark matter' yields new antibiotic.
Kingwell K. Kingwell K. Nat Rev Drug Discov. 2023 Sep 28. doi: 10.1038/d41573-023-00156-z. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37770758 No abstract available.
Rewired proteostasis in KRAS inhibitor resistance.
Eccleston A. Eccleston A. Nat Rev Drug Discov. 2023 Sep 27. doi: 10.1038/d41573-023-00155-0. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37758873 No abstract available.
Antipsychotic displays dual GPCR binding mode.
Crunkhorn S. Crunkhorn S. Nat Rev Drug Discov. 2023 Sep 26. doi: 10.1038/d41573-023-00154-1. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37752339 No abstract available.
Drug delivery systems for CRISPR-based genome editors.
Madigan V, Zhang F, Dahlman JE. Madigan V, et al. Nat Rev Drug Discov. 2023 Sep 18. doi: 10.1038/s41573-023-00762-x. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37723222 Review.
Pushing both sides of the drug pricing aisle.
Mullard A. Mullard A. Nat Rev Drug Discov. 2023 Oct;22(10):779-780. doi: 10.1038/d41573-023-00153-2. Nat Rev Drug Discov. 2023. PMID: 37709857 No abstract available.
Macrocycle drugs serve up new opportunities.
Kingwell K. Kingwell K. Nat Rev Drug Discov. 2023 Oct;22(10):771-773. doi: 10.1038/d41573-023-00152-3. Nat Rev Drug Discov. 2023. PMID: 37697066 No abstract available.
Artificial intelligence for natural product drug discovery.
Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, Meijer D, Terlouw BR, Biermann F, Blin K, Durairaj J, Gorostiola González M, Helfrich EJN, Huber F, Leopold-Messer S, Rajan K, de Rond T, van Santen JA, Sorokina M, Balunas MJ, Beniddir MA, van Bergeijk DA, Carroll LM, Clark CM, Clevert DA, Dejong CA, Du C, Ferrinho S, Grisoni F, Hofstetter A, Jespers W, Kalinina OV, Kautsar SA, Kim H, Leao TF, Masschelein J, Rees ER, Reher R, Reker D, Schwaller P, Segler M, Skinnider MA, Walker AS, Willighagen EL, Zdrazil B, Ziemert N, Goss RJM, Guyomard P, Volkamer A, Gerwick WH, Kim HU, Müller R, van Wezel GP, van Westen GJP, Hirsch AKH, Linington RG, Robinson SL, Medema MH. Mullowney MW, et al. Nat Rev Drug Discov. 2023 Sep 11. doi: 10.1038/s41573-023-00774-7. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37697042 Review.
Upcoming market catalysts in Q4 2023.
Putnam S. Putnam S. Nat Rev Drug Discov. 2023 Oct;22(10):778. doi: 10.1038/d41573-023-00151-4. Nat Rev Drug Discov. 2023. PMID: 37684344 No abstract available.
Defining rare conditions in the era of personalized medicine.
O'Connor DJ, Gabaldo M, Aartsma-Rus A, Hechtelt Jonker A. O'Connor DJ, et al. Nat Rev Drug Discov. 2023 Sep 8. doi: 10.1038/d41573-023-00145-2. Online ahead of print. Nat Rev Drug Discov. 2023. PMID: 37684343 No abstract available.
4,286 results